Expression of co-stimulatory factor B7-2 on the intrahepatic bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis: An immunohistochemical study

Journal of Pathology

Volumn 186, Issue 2, 1998, Pages 126-130

  Tsuneyama, Koichi ^a   Harada, Kenichi ^a   Yasoshima, Mitsue ^a   Kaji, Kyosuke ^a   Gershwin, M Eric ^b   Nakanuma, Yasuni ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

B7 2; Co stimulatory factor; Intrahepatic small bile ducts; Primary biliary cirrhosis; Primary sclerosing cholangitis

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN;

ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; BILIARY CIRRHOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCLEROSING CHOLANGITIS;

ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, CD86; BILE DUCTS, INTRAHEPATIC; CHOLANGITIS, SCLEROSING; CHOLESTASIS, EXTRAHEPATIC; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER CIRRHOSIS, BILIARY; MEMBRANE GLYCOPROTEINS; MICROSCOPY, CONFOCAL;

EID: 0031697120     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(1998100)186:2<126::AID-PATH167>3.0.CO;2-1     Document Type: Article

References (28)

1. Scheuer PJ. Liver Biopsy Interpretation. 3rd and 4th edns. London: Bailliere Tindall, 1980 and 1988.
2. Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1996; 21: 1570-1580.
3. Leevy CM (ed.). Diseases of the Liver and Biliary Tract: Standardization of Nomenclature. Diagnostic Criteria and Prognosis. New York: Raven Press, 1994.
4. Nakanuma Y, Ohta G. Histometric and serial section observations of the intrahepatic bile ducts in primary biliary cirrhosis. Gastroenterology 1979; 76: 1326-1332.
5. Gershwin ME, Mackay R, Coppel R, Nakanuma Y. Clinical immunological and molecular features of primary biliary cirrhosis. Semin Clinic Immunol 1994; 7: 5-16.
6. Nakanuma Y, Tsuneyama K, Gershwin ME, Yasoshima M. Pathology and immunopathology of primary biliary cirrhosis with emphasis on bile duct lesions: recent progress. Semin Liver Dis 1995; 15: 313-328.
7. Tsuneyama K, Van de Water J, Leung PSC, et al. Abnormal expression of the E2 component of the pyruvate dehydrogenase complex of the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BB1/B7 expression. Hepatology 1995; 21: 1031-1037.
8. Van de Water J, Turchany J, Leung PSC, et al. Molecular mimicry in primary biliary cirrhosis: evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2. J Clin Invest 1993; 91: 2653-2664.
9. Nakanuma Y, Tsuneyama K, Kohno N, Hoso M, Van de Water J, Gershwin ME. Biliary epithelial expression of pyruvate dehydrogenase complex in primary biliary cirrhosis: an immunohistochemical and immunoelectron microscopic study. Hum Pathol 19XX; 26: 92-98.
10. Nakanuma Y, Kono N. Expression of HLA-DR antigens on interlobular bile ducts in primary biliary cirrhosis and other hepatobiliary diseases: an immunohistochemical study. Hum Pathol 1991; 22: 431-436.
11. Yasoshima M, Nakanuma Y, Tsuneyama K, Van de Water J, Gerschwin ME. Immunohistochemical analysis of adhesion molecules in the microenvironment of portal tracts in relation to aberrant expression of PDC-E2 and HLA-DR on the bile ducts in primary biliary cirrhosis. J Pathol 1995; 175: 319-325.
12. Demetris AJ, Sever C, Kakizoe S, Oguma S, Starzl TE, Jaffe R. S100 protein positive dendritic cells in primary biliary cirrhosis and other chronic inflammatory liver diseases. Relevance to pathogenesis? Am J Pathol 1989; 134: 741-747.
13. Schwartz RH. Costimulation of lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 1992; 71: 1245-1249.
14. Janeway CA Jr, Bottomly K. Signals and signs for lymphocyte responses. Cell 1994; 71: 1065-1068.
15. Azuma M, Yssel H, Phillips JH, Spits H, Lanier LL. Functional expression of B7/BB1 on activated T lymphocytes. J Exp Med 1993; 177: 845-850.
16. Bluestone JA. New perspective of CD28-B7-mediated T cell costimulation. Immunity 1995; 2: 555-559.
17. Leon MP, Kirby JA, Gibbs P, Burt AD, Bassendine ME. Immunogenicity of biliary cells: study of the expression of B7 molecules. J Hepatol 1995; 22: 591-595.
18. Kaji K, Tsuneyama K, Nakanuma Y, et al. B7-2 positive cells around interlobular bile ducts in primary biliary cirrhosis and chronic hepatitis C. J Gastroenterol Hepatol in press).
19. Ludwig J. Surgical pathology of the syndrome of primary sclerosing cholangitis. Am J Surg Pathol 1989; 13: 43.
20. Cattoretti G, Pileri S, Parravicini C, et al. Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Pathol 1993; 171: 83-98.
21. Torii T, Takahashi A, Dohi A, Statistics for Medicine and Biology. Tokyo: Tokyo University Press, 1973: 1-37 (in Japanese).
22. Lenschow DJ, Ho SC, Satter H, et al. Differential effect of anti-B7-1 and B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med 1995; 181: 1145-1155.
23. Hathcock KS, Laszlo G, Pucillo C, Linsley P, Hodes RJ. Comparative analysis of B7-1 and B7-2 costimulatory ligands expression and function. J Exp Med 1994; 180: 631-640.
24. Freeman GJ, Boussiotis VA, Anumanthan A, et al. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 1995; 2: 523-532.
25. Kuchroo VK, Prabhu DAS MR, Brown JA, et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995; 80: 707-718.
26. Sethna MP, Van Parijis L, Sharpe AH, Abbas AK, Freeman GJ. A negative regulatory function of B7 revealed in B7-1 transgenic mice. Immunity 1994; 1: 415-421.
27. Azuma M. Costimulatory factors in stimulation of T cells. Infect Inflamm Immun 1995; 25: 168-176.
28. Martinez OM, Villanueva JC, Gershwin ME, Krams SM. Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis. Hepatology 1995; 21: 113-119.